Atrys Health Sa Stock Net Asset
| A2T Stock | EUR 3.00 0.01 0.33% |
ATRYS HEALTH SA fundamentals help investors to digest information that contributes to ATRYS HEALTH's financial success or failures. It also enables traders to predict the movement of ATRYS Stock. The fundamental analysis module provides a way to measure ATRYS HEALTH's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ATRYS HEALTH stock.
ATRYS |
ATRYS HEALTH SA Company Net Asset Analysis
ATRYS HEALTH's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
| Competition |
Based on the recorded statements, ATRYS HEALTH SA has a Net Asset of 0.0. This indicator is about the same for the Healthcare average (which is currently at 0.0) sector and about the same as Biotechnology (which currently averages 0.0) industry. This indicator is about the same for all Germany stocks average (which is currently at 0.0).
ATRYS Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ATRYS HEALTH's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ATRYS HEALTH could also be used in its relative valuation, which is a method of valuing ATRYS HEALTH by comparing valuation metrics of similar companies.ATRYS HEALTH is currently under evaluation in net asset category among its peers.
ATRYS Fundamentals
| EBITDA | 6.68 M | |||
| Net Income | (2.02 M) | |||
| Cash And Equivalents | 17.6 M | |||
| Cash Per Share | 0.51 X | |||
| Total Debt | 71.4 M | |||
| Debt To Equity | 0.95 % | |||
| Current Ratio | 1.74 X | |||
| Book Value Per Share | 1.53 X | |||
| Cash Flow From Operations | (1.4 M) | |||
| Earnings Per Share | (0.05) X | |||
| Number Of Employees | 2.4 K | |||
| Beta | 0.15 | |||
| Market Capitalization | 330.53 M | |||
| Z Score | 2.4 |
About ATRYS HEALTH Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ATRYS HEALTH SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ATRYS HEALTH using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ATRYS HEALTH SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in ATRYS Stock
ATRYS HEALTH financial ratios help investors to determine whether ATRYS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ATRYS with respect to the benefits of owning ATRYS HEALTH security.